S. Dawbaa Et Al. , "Biological activity evaluation of novel monoamine oxidase inhibitory compounds targeting Parkinson disease," FUTURE MEDICINAL CHEMISTRY , vol.14, no.22, pp.1663-1679, 2022
Dawbaa, S. Et Al. 2022. Biological activity evaluation of novel monoamine oxidase inhibitory compounds targeting Parkinson disease. FUTURE MEDICINAL CHEMISTRY , vol.14, no.22 , 1663-1679.
Dawbaa, S., Evren, A. E., Sağlık, B. N., Gündoğdu-Karaburun, N., & Karaburun, A. Ç., (2022). Biological activity evaluation of novel monoamine oxidase inhibitory compounds targeting Parkinson disease. FUTURE MEDICINAL CHEMISTRY , vol.14, no.22, 1663-1679.
Dawbaa, Sam Et Al. "Biological activity evaluation of novel monoamine oxidase inhibitory compounds targeting Parkinson disease," FUTURE MEDICINAL CHEMISTRY , vol.14, no.22, 1663-1679, 2022
Dawbaa, Sam Et Al. "Biological activity evaluation of novel monoamine oxidase inhibitory compounds targeting Parkinson disease." FUTURE MEDICINAL CHEMISTRY , vol.14, no.22, pp.1663-1679, 2022
Dawbaa, S. Et Al. (2022) . "Biological activity evaluation of novel monoamine oxidase inhibitory compounds targeting Parkinson disease." FUTURE MEDICINAL CHEMISTRY , vol.14, no.22, pp.1663-1679.
@article{article, author={Sam Dawbaa Et Al. }, title={Biological activity evaluation of novel monoamine oxidase inhibitory compounds targeting Parkinson disease}, journal={FUTURE MEDICINAL CHEMISTRY}, year=2022, pages={1663-1679} }